+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glaucoma Drug"

Antiglaucoma Drugs Global Market Report 2024 - Product Thumbnail Image

Antiglaucoma Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Glaucoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glaucoma Therapeutics - Global Strategic Business Report

  • Report
  • July 2024
  • 193 Pages
  • Global
From
From
Glaucoma Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Glaucoma Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Glaucoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Glaucoma - Epidemiology Forecast - 2034

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Open-Angle Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Uveitic Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Uveitic Glaucoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Primary Open Angle Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Open Angle Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Ocular Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Ocular Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
From
From
Loading Indicator

The Glaucoma Drug market is a subset of the Optical Disorders Drugs market, which includes medications used to treat a variety of eye conditions. Glaucoma is a group of eye diseases that cause damage to the optic nerve, resulting in vision loss. Glaucoma drugs are used to reduce intraocular pressure, which is the main risk factor for glaucoma. These drugs can be administered orally, topically, or through injections. Commonly used glaucoma drugs include prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors, and cholinergic agonists. Some of the major companies in the Glaucoma Drug market include Allergan, Pfizer, Merck, Novartis, Bausch Health, Sun Pharmaceuticals, Santen Pharmaceuticals, and Alcon. Show Less Read more